CMS Proposes Significant 2027 Changes to Medicare Advantage Payments and Compliance

The Centers for Medicare & Medicaid Services has released its proposed updates for the Medicare Advantage and Part D programs for 2027. These changes may look technical, but they could have a real financial effect on health plans, providers, and investors involved in Medicare Advantage.

CMS expects Medicare Advantage plans may see a payment increase of around 2% to 4%, depending on the final rates and each plan’s situation. Even a small change in that range can mean a large shift in revenue. For some organizations, it could affect millions of dollars each year.

The bigger issue is not just whether payments go up or down. It is also about how CMS plans to review those payments and how much risk organizations may face if their coding or documentation does not meet the required standards.

CMS continues to tighten risk adjustment rules

One of the biggest parts of the proposal is CMS’s continued update of the risk adjustment model used to set Medicare Advantage payments. The agency is moving ahead with revised Hierarchical Condition Categories, also known as HCCs, and continues to reduce the effect of coding intensity on payment.

CMS is also making its position clear on documentation. Diagnoses used for payment must be supported by medical records created at the time of care and must reflect conditions that were active and addressed.

This matters because some organizations have relied heavily on coding practices that increase risk scores. CMS is now trying to make sure those scores better match the patient’s true clinical condition. As a result, some diagnoses may carry less payment value, and some organizations may see lower risk scores unless their records strongly support the conditions reported.

Audit and compliance pressure is growing

CMS is also placing more focus on audits and program integrity. The agency continues to expand Risk Adjustment Data Validation audits and is paying closer attention to diagnosis reporting and supporting records.

In simple terms, this means payments linked to diagnosis coding are facing more review. Coding done after a patient visit, especially through chart reviews or outside vendors, may bring in more revenue in the short term. But it also creates more risk if the records do not fully support the diagnosis.

This is no longer just an audit issue. In some cases, it can also lead to False Claims Act investigations. Federal agencies are looking closely at whether retrospective coding practices have led to unsupported diagnoses and higher payments than allowed. That can result in repayment demands, penalties, and in serious cases, even criminal exposure.

What this could mean for providers

These changes may have a wide effect because Medicare Advantage now covers a large share of Medicare beneficiaries. When CMS changes payment methods, even slightly, the impact can spread across the healthcare system.

Providers and healthcare groups that depend heavily on risk-adjusted revenue may feel the most pressure. This is especially true for organizations that rely on high coding intensity or retrospective diagnosis capture. Even a small drop in risk scores can lead to a meaningful drop in revenue when large patient populations are involved.

Health plans may also respond by pushing more responsibility onto providers through contracts and closer coding oversight. In some arrangements, providers may have to absorb the financial impact of unsupported diagnoses, even if the coding work involved a health plan or a third-party vendor.

Why investors should pay attention

These proposed changes also matter for private equity firms and other healthcare investors. Many healthcare platforms now depend heavily on Medicare Advantage revenue.

That means investors need to look beyond headline payment increases. They also need to examine how stable that revenue really is. If growth has been supported by aggressive coding or retrospective review programs, the real question is whether that revenue can hold up under audit and compliance review.

Changes in payment policy and stronger enforcement can affect both current cash flow and future valuation. For that reason, documentation quality and compliance strength are becoming more important in investment analysis.

Conclusion

CMS’s 2027 proposals show that Medicare Advantage is moving toward tighter payment review and stronger oversight. The goal is to improve payment accuracy and reduce unsupported claims. For providers, health plans, and investors, the message is clear: revenue strategy and compliance can no longer be treated as separate issues.
Organizations that review their coding practices, documentation standards, and financial exposure now will be better prepared for what comes next